Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Kontaktformulär








 


OBS! Vill du ha svar, ange e-post eller telefonnummer!




Jan Lycke

Professor, adjungerad

Jan Lycke
Professor, adjungerad
Akademisk grad: Docent,
jan.lycke@gu.se
0 31-342 9047
0733-109149

Postadress: Gröna stråket 11, plan 3, 41345 Göteborg
Besöksadress: Neurosjukvården, Gröna stråket 11, plan 3, SU/Sahlgrenska sjukhuset , 41345 Göteborg


Sektionen för klinisk neurovetenskap vid Institutionen för neurovetenskap och fysiologi (Mer information)
Box 430
405 30 Göteborg
Besöksadress: Blå stråket 7, plan 3, Sahlgrenska , 413 45 Göteborg

Senaste publikationer

Blood neurofilament light levels segregate treatment effects in multiple sclerosis
Bénédicte Delcoigne, Ali Manouchehrinia, Christian Barro, Pascal Benkert, Zuzanna Michalak et al.
Neurology, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Peter Alping, Johan Askling, Joachim Burman, Katharina Fink, Anna Fogdell-Hahn et al.
Annals of Neurology, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
Anna He, Bernd Merkel, James William L Brown, Lana Zhovits Ryerson, Ilya Kister et al.
The Lancet. Neurology, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

Infection Risks among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
G. Luna, P. Alping, J. Burman, K. Fink, A. Fogdell-Hahn et al.
JAMA Neurology, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS
Mathias Granqvist, Joachim Burman, Martin Gunnarsson, Jan Lycke, Petra Nilsson et al.
Multiple Sclerosis Journal, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis.
Åsa P Sandelius, Sofia Sandgren, Markus Axelsson, Clas Malmeström, Lenka Novakova et al.
Scientific reports, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
Claire Bridel, Wessel N van Wieringen, Henrik Zetterberg, Betty M Tijms, Charlotte E Teunissen et al.
JAMA neurology, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies
G. Comi, R. Alroughani, A. L. Boster, A. D. Bass, R. Berkovich et al.
Multiple Sclerosis Journal, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

An unexpectedly high occurrence of aciclovir-induced neuropsychiatric symptoms in patients treated for herpesvirus CNS infection: a prospective observational study.
Johan Lindström, Anders Helldén, Jan Lycke, Anna Grahn, Marie Studahl
The Journal of antimicrobial chemotherapy, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies
B. Van Wijmeersch, B. A. Singer, A. Boster, S. Broadley, O. Fernandez et al.
Multiple Sclerosis Journal, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Visar 1 - 10 av 77

2020

Blood neurofilament light levels segregate treatment effects in multiple sclerosis
Bénédicte Delcoigne, Ali Manouchehrinia, Christian Barro, Pascal Benkert, Zuzanna Michalak et al.
Neurology, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Peter Alping, Johan Askling, Joachim Burman, Katharina Fink, Anna Fogdell-Hahn et al.
Annals of Neurology, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
Anna He, Bernd Merkel, James William L Brown, Lana Zhovits Ryerson, Ilya Kister et al.
The Lancet. Neurology, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

Infection Risks among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
G. Luna, P. Alping, J. Burman, K. Fink, A. Fogdell-Hahn et al.
JAMA Neurology, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

2019

Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS
Mathias Granqvist, Joachim Burman, Martin Gunnarsson, Jan Lycke, Petra Nilsson et al.
Multiple Sclerosis Journal, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis.
Åsa P Sandelius, Sofia Sandgren, Markus Axelsson, Clas Malmeström, Lenka Novakova et al.
Scientific reports, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
Claire Bridel, Wessel N van Wieringen, Henrik Zetterberg, Betty M Tijms, Charlotte E Teunissen et al.
JAMA neurology, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies
G. Comi, R. Alroughani, A. L. Boster, A. D. Bass, R. Berkovich et al.
Multiple Sclerosis Journal, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

An unexpectedly high occurrence of aciclovir-induced neuropsychiatric symptoms in patients treated for herpesvirus CNS infection: a prospective observational study.
Johan Lindström, Anders Helldén, Jan Lycke, Anna Grahn, Marie Studahl
The Journal of antimicrobial chemotherapy, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies
B. Van Wijmeersch, B. A. Singer, A. Boster, S. Broadley, O. Fernandez et al.
Multiple Sclerosis Journal, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Visar 1 - 10 av 77

Sidansvarig: Katinka Almrén|Sidan uppdaterades: 2015-09-01
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?

Denna text är utskriven från följande webbsida:
http://neurophys.gu.se/sektioner/klinisk-neurovetenskap/om-sektionen/personal/?feedbackForm=true&returnAddress=http%3A%2F%2Fneurophys.gu.se%2Fsektioner%2Fklinisk-neurovetenskap%2Fom-sektionen%2Fpersonal%2F%3FtipFriend%3Dtrue%26tipUrl%3Dhttp%253A%252F%252Fneurophys.gu.se%252Fsektioner%252Fklinisk-neurovetenskap%252Fom-sektionen%252Fpersonal%252F%253FlanguageId%253D100000%2526disableRedirect%253Dtrue%2526returnUrl%253Dhttp%25253A%25252F%25252Fneurophys.gu.se%25252Fenglish%25252Fdepartments%25252Fclinical_neuroscience_and_rehabilitation%25252Fabout-us%25252Fstaff%25252F%25253FfeedbackForm%25253Dtrue%252526returnAddress%25253Dhttp%2525253A%2525252F%2525252Fneurophys.gu.se%2525252Fenglish%2525252Fdepartments%2525252Fclinical_neuroscience_and_rehabilitation%2525252Fabout-us%2525252Fstaff%2525252F%2525253Fprint%2525253Dtrue%25252526languageId%2525253D100001%25252526userId%2525253Dxlycja%252526recipientName%25253DKatinka%25252BAlmr%252525E9n%252526encodedEmail%25253Da2F0aW5rYS5hbG1yZW5AbmV1cm8uZ3Uuc2U%252526print%25253Dtrue%252526languageId%25253D100001%252526userId%25253Dxlycja%2526feedbackForm%253Dtrue%2526returnAddress%253Dhttp%25253A%25252F%25252Fneurophys.gu.se%25252Fenglish%25252Fdepartments%25252Fclinical_neuroscience_and_rehabilitation%25252Fabout-us%25252Fstaff%25252F%25253Fprint%25253Dtrue%252526languageId%25253D100001%252526userId%25253Dxlycja%2526recipientName%253DKatinka%252BAlmr%2525E9n%2526encodedEmail%253Da2F0aW5rYS5hbG1yZW5AbmV1cm8uZ3Uuc2U%2526print%253Dtrue%2526userId%253Dxlycja%26languageId%3D100000%26disableRedirect%3Dtrue%26returnUrl%3Dhttp%253A%252F%252Fneurophys.gu.se%252Fenglish%252Fdepartments%252Fclinical_neuroscience_and_rehabilitation%252Fabout-us%252Fstaff%252F%253FfeedbackForm%253Dtrue%2526returnAddress%253Dhttp%25253A%25252F%25252Fneurophys.gu.se%25252Fenglish%25252Fdepartments%25252Fclinical_neuroscience_and_rehabilitation%25252Fabout-us%25252Fstaff%25252F%25253Fprint%25253Dtrue%252526languageId%25253D100001%252526userId%25253Dxlycja%2526recipientName%253DKatinka%252BAlmr%2525E9n%2526encodedEmail%253Da2F0aW5rYS5hbG1yZW5AbmV1cm8uZ3Uuc2U%2526print%253Dtrue%2526languageId%253D100001%2526userId%253Dxlycja%26feedbackForm%3Dtrue%26encodedEmail%3Da2F0aW5rYS5hbG1yZW5AbmV1cm8uZ3Uuc2U%26print%3Dtrue%26userId%3Dxlycja&recipientName=Katinka+Almr%E9n&encodedEmail=a2F0aW5rYS5hbG1yZW5AbmV1cm8uZ3Uuc2U&tipFriend=true&tipUrl=http%3A%2F%2Fneurophys.gu.se%2Fsektioner%2Fklinisk-neurovetenskap%2Fom-sektionen%2Fpersonal%2F%3FlanguageId%3D100000%26disableRedirect%3Dtrue%26returnUrl%3Dhttp%253A%252F%252Fneurophys.gu.se%252Fenglish%252Fdepartments%252Fclinical_neuroscience_and_rehabilitation%252Fabout-us%252Fstaff%252F%253FfeedbackForm%253Dtrue%2526returnAddress%253Dhttp%25253A%25252F%25252Fneurophys.gu.se%25252Fenglish%25252Fdepartments%25252Fclinical_neuroscience_and_rehabilitation%25252Fabout-us%25252Fstaff%25252F%25253Fprint%25253Dtrue%252526languageId%25253D100001%252526userId%25253Dxlycja%2526recipientName%253DKatinka%252BAlmr%2525E9n%2526encodedEmail%253Da2F0aW5rYS5hbG1yZW5AbmV1cm8uZ3Uuc2U%2526print%253Dtrue%2526languageId%253D100001%2526userId%253Dxlycja%26feedbackForm%3Dtrue%26returnAddress%3Dhttp%253A%252F%252Fneurophys.gu.se%252Fenglish%252Fdepartments%252Fclinical_neuroscience_and_rehabilitation%252Fabout-us%252Fstaff%252F%253Fprint%253Dtrue%2526languageId%253D100001%2526userId%253Dxlycja%26recipientName%3DKatinka%2BAlmr%25E9n%26encodedEmail%3Da2F0aW5rYS5hbG1yZW5AbmV1cm8uZ3Uuc2U%26print%3Dtrue%26userId%3Dxlycja&languageId=100000&disableRedirect=true&returnUrl=http%3A%2F%2Fneurophys.gu.se%2Fenglish%2Fdepartments%2Fclinical_neuroscience_and_rehabilitation%2Fabout-us%2Fstaff%2F%3FfeedbackForm%3Dtrue%26returnAddress%3Dhttp%253A%252F%252Fneurophys.gu.se%252Fenglish%252Fdepartments%252Fclinical_neuroscience_and_rehabilitation%252Fabout-us%252Fstaff%252F%253Fprint%253Dtrue%2526languageId%253D100001%2526userId%253Dxlycja%26recipientName%3DKatinka%2BAlmr%25E9n%26encodedEmail%3Da2F0aW5rYS5hbG1yZW5AbmV1cm8uZ3Uuc2U%26print%3Dtrue%26languageId%3D100001%26userId%3Dxlycja&userId=xlycja
Utskriftsdatum: 2020-07-10